Bioxyne Limited Stock

Equities

BXN

AU000000BXN6

Biotechnology & Medical Research

Market Closed - Australian S.E. 10:13:58 2024-07-02 pm EDT 5-day change 1st Jan Change
0.005 AUD 0.00% Intraday chart for Bioxyne Limited 0.00% -54.55%
Sales 2022 2.48M 1.67M Sales 2023 5.3M 3.57M Capitalization 38.03M 25.59M
Net income 2022 - 0 Net income 2023 -1M -673K EV / Sales 2022 2.22 x
Net cash position 2022 2.17M 1.46M Net cash position 2023 3.29M 2.21M EV / Sales 2023 6.55 x
P/E ratio 2022
-30.1 x
P/E ratio 2023
-13.9 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 22.01%
More Fundamentals * Assessed data
Dynamic Chart
3 months-44.44%
6 months-54.55%
Current year-54.55%
More quotes
1 week
0.01
Extreme 0.005
0.01
1 month
0.01
Extreme 0.005
0.01
Current year
0.01
Extreme 0.005
0.02
1 year
0.01
Extreme 0.005
0.02
3 years
0.01
Extreme 0.005
0.04
5 years
0.01
Extreme 0.005
0.04
10 years
0.01
Extreme 0.005
0.14
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-05-18
Comptroller/Controller/Auditor - -
Members of the board TitleAgeSince
Chairman 65 12-10-29
Director/Board Member - 23-05-18
Chief Executive Officer - 23-05-18
More insiders
Date Price Change Volume
24-07-03 0.005 0.00% 2,488
24-07-02 0.005 0.00% 77,079
24-07-01 0.005 0.00% 500,000
24-06-28 0.005 0.00% 196,579
24-06-27 0.005 0.00% 60,000

Delayed Quote Australian S.E., July 02, 2024 at 10:13 pm EDT

More quotes
Bioxyne Limited is an Australia-based international consumer health and pharmaceutical company. The Company is focused on health and wellness products, psychotropic and investigational medicines. The Company operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The Company direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.
More about the company